SYRE compared with ORKA: revenue, margins and what each company keeps, and the suppliers and customers both name

SYRESpyre Therapeutics, Inc.

Mkt capRevenueRevenue

ORKAOruka Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

SYRESpyre Therapeutics, Inc.

ORKAOruka Therapeutics, Inc.

Price

Mkt cap

Revenue

Co-movers

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

daily closes · 500dMethod ›

Moved together

SYREwithORKA

×0.57co-movement · ORKA on SYRE · 500d

r 0.51scale to r 0.75

Shared co-movers4with SYREwith ORKA

APGEApogee Therapeutics, Inc.r 0.52r 0.42

CGONCG Oncology, Inc.r 0.48r 0.41

XNCRXencor Incr 0.45r 0.39

NRIXNurix Therapeutics, Inc.r 0.46r 0.36

SYRE, solidORKA, hatched× = co-movement · βr = correlationBar = r to r 0.75Order: weaker of A and BSource: daily closes

SYRESpyre Therapeutics, Inc.

96.44▼−2.55%

Mkt cap$8.5B

ORKAOruka Therapeutics, Inc.

96.24▼−0.42%· post 98.76

ClosedOct 30 '26

Mkt cap$6.4B

Compare

ClosedOct 30 '26

SYRESpyre Therapeutics, Inc.

ORKAOruka Therapeutics, Inc.

96.44▼−2.55%

Price

96.24▼−0.42%post 98.76

$8.5B

Mkt cap

$6.4B

SYRE96.44▼−2.55%vsORKA96.24▼−0.42%ClosedOct 30 '26